[Pathologic evaluation of breast cancer specimens after neoadjuvant chemotherapy].
Tang
Feng
F
Department of Pathology, Univeristy of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA.
Wu
Yun
Y
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D020360:Neoadjuvant Therapy; D018365:Neoplasm, Residual
D000970:Antineoplastic Agents